Dr. Saw Discusses Study of Vitamin D in Melanoma

Robyn Saw, FRACS, MS, MBBS
Published: Monday, Oct 30, 2017



Robyn Saw, FRACS, MS, MBBS, associate professor of surgery, The University of Sydney, discusses a study of vitamin D in melanoma.

This phase II study aims to find an alternative therapy option for patients with melanoma who are at high risk for recurrence. Currently, the only option for these patients is surgery.

In the study, patients received adjuvant therapy with high-dose vitamin D following primary treatment. Vitamin D has shown potential to delay recurrence and improve prognosis. Currently, there is no effective nontoxic adjuvant therapy for this population.
 


Robyn Saw, FRACS, MS, MBBS, associate professor of surgery, The University of Sydney, discusses a study of vitamin D in melanoma.

This phase II study aims to find an alternative therapy option for patients with melanoma who are at high risk for recurrence. Currently, the only option for these patients is surgery.

In the study, patients received adjuvant therapy with high-dose vitamin D following primary treatment. Vitamin D has shown potential to delay recurrence and improve prognosis. Currently, there is no effective nontoxic adjuvant therapy for this population.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Publication Bottom Border
Border Publication
x